切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2014, Vol. 03 ›› Issue (02) : 91 -94. doi: 10.3877/cma.j.issn.2095-3224.2014.02.04

所属专题: 文献

青年专家论坛

不可切除的结直肠癌肝转移灶局部治疗进展
郑鹏1, 任黎1,()   
  1. 1. 200032 上海,复旦大学中山医院普外科
  • 收稿日期:2014-03-07 出版日期:2014-04-25
  • 通信作者: 任黎
  • 基金资助:
    上海市科委启明星计划(12QA1400600)

Advances in local treatment of unresectable liver metastasis from colorectal cancer

Peng ZHENG1, Li REN1,()   

  1. 1. General Surgery of Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2014-03-07 Published:2014-04-25
  • Corresponding author: Li REN
  • About author:
    Corresponding author: REN Li, Email:
引用本文:

郑鹏, 任黎. 不可切除的结直肠癌肝转移灶局部治疗进展[J/OL]. 中华结直肠疾病电子杂志, 2014, 03(02): 91-94.

Peng ZHENG, Li REN. Advances in local treatment of unresectable liver metastasis from colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2014, 03(02): 91-94.

肝脏是结直肠癌发生转移最主要的靶器官,手术切除是治疗肝转移最理想的方式,但对于不可切除的肝转移,局部控制是治疗的首要目标,在全身化疗的基础上,局部治疗发挥了重要的强化和补充作用。目前常用的局部治疗方式包括消融治疗、肝脏导向化疗、放射治疗等。近年来这些方式在低毒副作用、高可重复性、长期控制等方向均有一定的进展。

Liver is the most common metastasis organ of colorectal caner.For recectable CLMs(colorectal liver metastasis), radical resection is the optimal choice, whereas, for unresectable ones, local control is the priority.Local treatments significantly enhance or complement the systematic chemotherapy, which is worldwide standard-of-care for unresectable CLMs.Nowadays, Local treatments consist of thermal ablation, liver-oriented chemotherapy, radiotherapy and so on.There have achieved many breakthroughs, making local treatments less poisoning, highly repeatable and able to get longtime control.

[1]
Pathak S,Jones R,Tang JM,et al:Ablative therapies for colorectal liver metastases:A systematic review.Colorectal Dis,2011,13:252-265.
[2]
Ruers T,Punt C,Van Coevorden F,et al.Radiofrequency ablation combined with systemic treatment versus systemic treatment alone inpatients with non-resectable colorectal liver metastases:a randomized EORTC Intergroup phase II study(EORTC 40004).Ann Oncol,2012,23:2619-2626.
[3]
Evrard S,Rivoire M,Arnaud J,et al.Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection.Br J Surg,2012,99:558-565.
[4]
Schullian P,Weiss H,Klaus A,et al.Laparoscopic liver packing to protect surrounding organs during thermal ablation.Minim Invasive Ther Allied Technol,2014.
[5]
Thanos L,Mylona S,Galani P,et al.Overcoming the heat-sink phenomenon:successful radiofrequency thermal ablation of liver tumors in contact with blood vessels.Diagn Interv Radiol,2008,14(1):51-56.
[6]
Jones RP,Kitteringham NR,Terlizzo M,et al.Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator.Int J Hyperthermia,2012,28(1):43-54.
[7]
Schuld J,Richter S,Oberkircher LW,et al.Evidence for tumor cell spread during local hepatic ablation of colorectal liver metastases.J Surg Res,2012,178(1):268-279.
[8]
Orsi F,Zhang L,Arnone P,et al.High-intensity focused ultrasound ablation:effective and safe therapy for solid tumors in difficult locations.AJR Am J Roentgenol,2010,195(3):W245-252.
[9]
Elias D,Baton O,Sideris L,et al.Hepatectomy plus intraoperative radiofrequency ablation and chemotherapy to treat technically unresectable multiple colorectal liver metastases.J Surg Oncol,2005,90:36-42.
[10]
Livraghi T,Solbiati L,Meloni F,et al.Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection:the "test-of-time approach" .Cancer,2003,97:3027-3035.
[11]
Mocellin S,Pilati P,Lise M,et al.Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer:the end of an era? J Clin Oncol,2007,25:5649–5654.
[12]
Kemeny NE,Melendez FD,Capanu M,et al.Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.J Clin Oncol,2009,27:3465–3471.
[13]
Albert M,Kiefer M,Sun W,et al.Chemoembolization of colorectal liver metastases with cisplatin,doxorubicin,mitomycin C,ethiodol,and polyvinyl alcohol.Cancer,2011,117(2):343-352.
[14]
Fiorentini G,Aliberti C,Tilli M,et al.Intra-arterial infusion of irinotecan-loaded drug-eluting beads(DEBIRI)versus intravenous therapy(FOLFIRI)for hepatic metastases from colorectal cancer:Final results of a phase III study.Anticancer Res,2012,32:1387-1396.
[15]
Engels.Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer.Radiation Oncology,2012,7:34.
[16]
Young Seok Seo,Mi-Sook Kim,Hyung-Jun Yoo,et al.Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.World J Gastroenterol,2014,20(8):2005-2013.
[17]
Sofocleous CT,Garcia AR,Pandit-Taskar N,et al.Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy.Clin Colorectal Cancer,2014,13(1):27-36.
[18]
Vente MAD,Wondergem M,Tweel I,et al.Yttrium-90 microsphere radioembolization for the treatment of liver malignancies:a structured meta-analysis.European Radiology,2009,19(4):951–959.
[19]
Hipps D,Ausania F,Manas DM,et al.Selective Interarterial Radiation Therapy(SIRT)in Colorectal Liver Metastases:How Do We Monitor Response?HPB Surgery,2013,1-10.
[20]
王锡山.从ESMO共识看结直肠癌肝转移的治疗策略.中华结直肠疾病电子杂志,2014,3(1):9-11.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[4] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[5] 陆思楠, 苏同荣, 张启逸. 索凡替尼转化治疗胰腺神经内分泌肿瘤肝转移一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 526-530.
[6] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[7] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[8] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[9] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[10] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[11] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[12] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[13] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[14] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[15] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?